1,3-butadiynamide 1a (48 mg, 0.10 mmol), tetrakis(triphenylphosphine)palladium(0) (12 mg, 0.01 mmol, 10 mol%) and t-BuOK (28 mg, 0.25 mmol, 2.5 equiv) were introduced in a dry Schlenk tube under argon atmosphere. Then CD3OD (0.75 mL) was added. The Schlenk tube was sealed and immediately placed in an oil bath preheated to 70 °C. After 30 min, the reaction mixture was diluted with EtOAc and washed with brine. After drying (MgSO4), the organic layer was filtered and evaporated under reduced pressure. The product was purified via column chromatography (SiO2 pretreated with n-pentane/Et2O/Et3N 94:2:2 (v/v/v), n-pentane/Et2O 98:2 to 95:5 (v/v)) to yield 8a as an oil (13.5 mg, 0.058 mmol, yield: 58%). Rf = 0.72 (n-pentane/Et2O 10:1 (v/v)).
D5-2-Methoxy-4-(pent-1-en-1-yl)quinoline (8a). 1H NMR (500 MHz, CDCl3) δ 7.98 (dd, 3J = 8.3 Hz, 4J = 1.0 Hz, 1 H, H5), 7.90 (m, 1 H, H8), 7.62 (ddd, 3J = 8.3 Hz, 3J = 7.0 Hz, 4J = 1.2 Hz, 1 H, H7), 7.39 (ddd, 3J = 8.1 Hz, 3J = 7.0 Hz, 4J = 1.0 Hz, 1 H, H6), 6.42 (tt, 3J = 7.0 Hz, 3J = 2 Hz, 1 H, H12), 2.32 (qapp, 3J = 7.2 Hz, 2 H, H13), 1.57 (sext, 3J = 7.4 Hz, 2 H, H14) and 1.00 (t, 3J = 7.4 Hz, 3 H, H15). HRMS (ESI+): Calc’d for C15H13D5NO [M + H]+: 233.1702; found: 233.1704.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.